Crossmark

A Phase I Dose-Escalation and Bioequivalence Study of a Trastuzumab Biosimilar in Healthy Male Volunteers

Crossref DOI link: https://doi.org/10.1007/s40261-014-0247-5

Published Online: 2014-11-07

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wisman, Liselijn A. B.

De Cock, Eduard P. M.

Reijers, Joannes A. A.

Kamerling, Ingrid M. C.

Van Os, Sandra H. G.

de Kam, Marieke L.

Burggraaf, Jacobus

Voortman, Gerrit
License Information

Text and Data Mining valid from 2014-11-07